Today in Science
SEE OTHER BRANDS

Fresh science news from the world

Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

Press releases published on June 17, 2025

Aptose Provides Corporate Updates

Aptose Provides Corporate Updates

Announces short-term cash advance SAN DIEGO and TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company, announced today that the Company has secured …

Communiqué de presse : Sanofi place 1,5 milliard d’euros d’emprunts obligataires

Communiqué de presse : Sanofi place 1,5 milliard d’euros d’emprunts obligataires

  Sanofi place 1,5 milliard d’euros d’emprunts obligataires  Paris, 17 juin 2025 - Sanofi annonce avoir placé avec succès une émission obligataire en 2 tranches (les « obligations ») pour un montant de 1,5 milliard d’euros :  750 millions d’euros d’ …

Press release: Sanofi successfully prices €1.5 billion bond issue

Press release: Sanofi successfully prices €1.5 billion bond issue

  Sanofi successfully prices €1.5 billion bond issue Paris, June 17, 2025 - Sanofi announces that it has successfully priced its offering of €1.5 billion of notes across 2 tranches:  €750 million fixed-rate notes, due June 2029, bearing interest at an …

Endogenex to Present Data on Endoscopic Procedure for Type 2 Diabetes at American Diabetes Association’s (ADA) 85th Scientific Sessions

Endogenex to Present Data on Endoscopic Procedure for Type 2 Diabetes at American Diabetes Association’s (ADA) 85th Scientific Sessions

MINNEAPOLIS, June 17, 2025 (GLOBE NEWSWIRE) -- Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes (T2D), will present results from its REGENT-1 Australia clinical study at the American …

Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy

Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy

NEW YORK and MELBOURNE, Australia, June 17, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company advancing combination drug therapies for high-impact indications, …

Cartier Awards All Contracts of Largest-Ever Drill Program on Cadillac

Cartier Awards All Contracts of Largest-Ever Drill Program on Cadillac

VAL-D’OR, Quebec, June 17, 2025 (GLOBE NEWSWIRE) -- Cartier Resources Inc. (TSXV: ECR; FSE: 6CA) (“Cartier″ or the “Company″) is pleased to announce it has awarded all contracts for its fully funded, 100,000-metre diamond drilling program at its 100%-owned …

Cartier octroie tous les contrats pour le plus important programme de forage jamais réalisé sur Cadillac

Cartier octroie tous les contrats pour le plus important programme de forage jamais réalisé sur Cadillac

VAL-D’OR, Québec, 17 juin 2025 (GLOBE NEWSWIRE) -- Ressources Cartier Inc. (TSXV : ECR; FSE : 6CA) (“Cartier″ ou la “Société″) est heureuse d'annoncer l’octroi de tous les contrats de son programme de forage au diamant de 100 000 mètres, entièrement …

Roadzen Partners with Global Energy Giant SHV Energy’s Indian Subsidiary, SUPERGAS, to Deploy AI-Powered ADAS Across Its LPG Fleet

Roadzen Partners with Global Energy Giant SHV Energy’s Indian Subsidiary, SUPERGAS, to Deploy AI-Powered ADAS Across Its LPG Fleet

SUPERGAS, India’s Leading LPG Company Selects Roadzen’s Platform DrivebuddyAI™ to Enhance Driver Monitoring, Reduce Accidents, and Meet Evolving Safety Mandates NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Roadzen Inc. (Nasdaq: RDZN) ("Roadzen" or the " …

Draganfly's Commander 3XL Integrated with TB2 Aerospace’s DROPS System Achieves 100% Success Rate During U.S. Army’s SMEX25 Operational Trials

Draganfly's Commander 3XL Integrated with TB2 Aerospace’s DROPS System Achieves 100% Success Rate During U.S. Army’s SMEX25 Operational Trials

In alignment with the Presidential Executive Order “Unleashing American Drone Dominance” Golden, CO, June 17, 2025 (GLOBE NEWSWIRE) -- TB2 Aerospace LLC, in collaboration with Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “ …

ReversingLabs Named to Inc.’s 2025 Best Workplaces List

ReversingLabs Named to Inc.’s 2025 Best Workplaces List

CAMBRIDGE, Mass., June 17, 2025 (GLOBE NEWSWIRE) -- ReversingLabs, the trusted name in file and software security, today announced it has been named to Inc.’s 2025 Best Workplaces list, honoring companies that have built exceptional workplaces and vibrant …

Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting

Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting

- Broad Use of Suprachoroidal Injection Platform Highlighted Across Retinal Indications - - CLS-AX Combines the Flexibility of Anti-VEGF Therapies with the Long-Lasting Benefits of a Tyrosine Kinase Inhibitor - ALPHARETTA, Ga., June 17, 2025 (GLOBE …

Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer

Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer

CHASKA, Minn., June 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has signed a new 10-year commercial …

Eccogene to Report Preclinical Data with ECC4703, Showcasing Impact on Lean Muscle Sparing and Fat Loss in Combination with Semaglutide and Tirzepatide

Eccogene to Report Preclinical Data with ECC4703, Showcasing Impact on Lean Muscle Sparing and Fat Loss in Combination with Semaglutide and Tirzepatide

BOSTON and SHANGHAI, June 17, 2025 (GLOBE NEWSWIRE) -- Eccogene, a clinical-stage biopharmaceutical company developing next-generation oral small molecule therapeutics for chronic cardiometabolic and inflammatory conditions, today announced that …

Tisento Therapeutics Receives U.S. FDA Fast Track Designation for Zagociguat for the Treatment of MELAS

Tisento Therapeutics Receives U.S. FDA Fast Track Designation for Zagociguat for the Treatment of MELAS

CAMBRIDGE, Mass., June 17, 2025 (GLOBE NEWSWIRE) -- Tisento Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to zagociguat for the treatment of MELAS (Mitochondrial Encephalomyopathy, Lactic …

Microbix Attending & Presenting at Asia Pacific POC 2025

Microbix Attending & Presenting at Asia Pacific POC 2025

MISSISSAUGA, Ontario, June 17, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is attending and presenting at the 2nd Asia Pacific Conference on …

Next-Gen Edge AI Solutions for the Real World: Autonomous Navigation for Drones, Surveillance and Robotics

Next-Gen Edge AI Solutions for the Real World: Autonomous Navigation for Drones, Surveillance and Robotics

IRVINE, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader in compute and connectivity IoT solutions enabling Edge AI Intelligence, today announced its collaboration with Aerora, a provider of integrated NDAA-compliant …

Kamada Confirms Continuous Global Business Operations and Products Availability Despite Recent Events in the Middle East

Kamada Confirms Continuous Global Business Operations and Products Availability Despite Recent Events in the Middle East

REHOVOT, Israel and HOBOKEN, N.J., June 17, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty …

Relmada Therapeutics Appoints Urology Expert Raj S. Pruthi, MD as CMO-Urology

Relmada Therapeutics Appoints Urology Expert Raj S. Pruthi, MD as CMO-Urology

Dr. Pruthi brings vast clinical development experience advancing novel therapies for NMIBC to Relmada and the NDV-01 program Phase 3 trial for NDV-01 expected to begin in H1 2026 CORAL GABLES, Fla., June 17, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, …

Troilus Drills 78.38 g/t AuEq Over 2 m, Including 153.73 g/t AuEq Over 1 m in the Southwest Zone

Troilus Drills 78.38 g/t AuEq Over 2 m, Including 153.73 g/t AuEq Over 1 m in the Southwest Zone

MONTREAL, June 17, 2025 (GLOBE NEWSWIRE) -- Troilus Gold Corp. (“Troilus” or the “Company”, TSX: TLG; OTCQX: CHXMF; FSE: CM5R) is pleased to announce the final assay results from the Southwest Zone (“Southwest”) as part of its ongoing 2025 Exploration …

Troilus Intercepte 78,38 g/t d’équ.-Or Sur 2 m, Incluant 153,73 g/t d’équ.-Or Sur 1 m dans la Zone Southwest

Troilus Intercepte 78,38 g/t d’équ.-Or Sur 2 m, Incluant 153,73 g/t d’équ.-Or Sur 1 m dans la Zone Southwest

MONTRÉAL, 17 juin 2025 (GLOBE NEWSWIRE) -- Troilus Gold Corp. (« Troilus » ou la « Société ») (TSX: TLG; OTCQX: CHXMF; FSE: CM5R) a le plaisir d’annoncer les résultats d’analyse finaux provenant de la zone Southwest («Southwest») dans le cadre de sa …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service